(Q40165243)

18 September 2017

1 reference

title

Hepatotoxicity following the therapeutic use of antipyretic analgesics (English)

1 reference

18 September 2017

1 reference

G. D. Benson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6359871

7 October 2023

language of work or name

English

0 references

publication date

1 November 1983

1 reference

18 September 2017

14 November 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6359871

full work available at URL

7 October 2023

https://api.elsevier.com/content/article/PII:0002934383902371?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

https://api.elsevier.com/content/article/PII:0002934383902371?httpAccept=text/plain

7 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

American Journal of Medicine

7 October 2023

published in

1 reference

18 September 2017

75

1 reference

18 September 2017

5A

1 reference

18 September 2017

85-93

1 reference

Serum Transaminases during Salicylate Therapy

18 September 2017

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Hepatic involvement in juvenile rheumatoid arthritis

7 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Follow-up study of 100 cases of juvenile rheumatoid arthritis

7 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Chronic toxic hepatitis caused by aspirin

7 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis

7 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis a prospective study

7 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis

7 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis

7 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Serum transaminases and salicylate therapy.

7 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Effect of aspirin on liver tests in patients with ra or sle and in normal volunteers

7 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Editorial: Aspirin-induced hepatic injury

7 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Letter: Aspirin hepatotoxicity

7 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Letter: Salicylate-induced hepatic injury

7 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Ultrastructural changes in aspirin hepatotoxicity

7 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

7 October 2023

Salicylate hepatitis

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Clinical Implications of Salicylate-Induced Liver Damage

7 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Encephalopathy and fatty liver (Reye's syndrome)

7 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Salicylate hepatotoxicity

7 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.

7 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin hepatotoxicity and disseminated intravascular coagulation

7 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin hepatitis associated with encephalopathy

7 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Hepatoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis

7 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases

7 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus

7 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

7 October 2023

Aspirin hepatotoxicity

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Aspirin-induced hepatic dysfunction in a patient with adult rheumatoid arthritis

7 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

7 October 2023

Aspirin Hepatitis

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Drug-induced chronic liver disease

7 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Hepatic damage due to aspirin

7 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.

7 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Potentiation by Previous Drug Therapy of Hepatotoxicity following Paracetamol Overdosage

7 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Effects of microsomal enzyme induction on paracetamol metabolism in man

7 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Chronic excessive acetaminophen use and liver damage

7 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Chronic liver disease and acetaminophen

7 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Chronic hepatic inflammation and fibrosis due to low doses of paracetamol

7 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acetaminophen and the Liver

7 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Apparent potentiation of acetaminophen hepatotoxicity by alcohol

7 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acetaminophen associated hepatic injury, Report of two cases showing unusual portal tract reactions

7 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acetaminophen and hepatic dysfunction in infectious mononucleosis

7 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Increased hepatic sensitivity to paracetamol

7 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Host susceptibility and acetaminophen liver injury

7 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Long-Term Ingestion of Paracetamol and Liver Disease1

7 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Letter: Paracetamol hepatoxicity

7 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Ethanol Increases Hepatic Smooth Endoplasmic Reticulum and Drug-Metabolizing Enzymes

7 October 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption

7 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.

7 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Elimination of paracetamol in chronic liver disease

7 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Paracetamol (Acetaminophen) Clearance in Patients with Cirrhosis of the Liver

7 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Acetaminophen in chronic liver disease

7 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Determination of drug metabolizing enzymes in needle biopsies of human liver

7 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Paracetamol metabolism in chronic liver disease

7 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

The hepatic glutathione content in liver diseases

7 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

Glutathione and glutathione-S-transferases in the normal and diseased human liver

7 October 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90237-1

7 October 2023

Identifiers

1 reference

18 September 2017

1 reference